![Naveen Pemmaraju: Delighted to spend some time at Atrium Health](https://oncodaily.com/pub/uploads/2024/08/Naveen-Pemmaraju.jpeg)
Naveen Pemmaraju: Delighted to spend some time at Atrium Health
Naveen Pemmaraju shared a post on X:
“Delighted to spend some time in Charlotte at Atrium Healt and Levine Cancer to see dear friend and my Co-Chair Ruben A. Mesa, as we kick off our exciting MPN Workshop of The Carolinas ‘24 in Asheville this week .
Please join us.“
Source: Naveen Pemmaraju/X
Naveen Pemmaraju is a Professor and Director of BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center (MDACC) and Executive Director of MDACC Network.
He is also the Leukemia Hematology/Oncology Course Director. His research work has been focused on improving outcomes and developing novel therapies for patients with rare, and ultra-rare, myeloid malignancies; including adolescents, young adults, and older adult patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), MPN and AML.
Dr. Ruben A. Mesa, MD, FACP, serves as the president and executive director of Atrium Health Levine Cancer Institute (LCI) and Atrium Health Wake Forest Baptist Comprehensive Cancer Center. Additionally, he holds the position of vice dean for cancer programs and professor of medicine at Wake Forest University School of Medicine.
He is an international expert in hematologic cancers, particularly myeloproliferative neoplasms (MPNs). Through his tireless efforts, Dr. Mesa continues to drive progress in the understanding and treatment of hematologic malignancies, offering hope to those affected by these complex diseases.